136 related articles for article (PubMed ID: 36328194)
1. Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD).
Yang Y; Cao L; Guo Z; Gu H; Zhang K; Qiu Z
Exp Cell Res; 2022 Dec; 421(2):113402. PubMed ID: 36328194
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract][Full Text] [Related]
3. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.
Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP
Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma.
Liu X; Chen B; Chen J; Su Z; Sun S
Cancer Sci; 2022 May; 113(5):1868-1879. PubMed ID: 35271750
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia.
Jiang L; He Q; Chen X; Liu A; Ding W; Zhang H; Chen X; Zhou H; Meng Y; Liu B; Peng G; Wang C; Liu J; Shi X
Clin Transl Med; 2022 Sep; 12(9):e1038. PubMed ID: 36082692
[TBL] [Abstract][Full Text] [Related]
6. Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.
Arpalahti L; Saukkonen K; Hagström J; Mustonen H; Seppänen H; Haglund C; Holmberg CI
Tumour Biol; 2017 Jun; 39(6):1010428317710411. PubMed ID: 28653876
[TBL] [Abstract][Full Text] [Related]
7. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
[No Abstract] [Full Text] [Related]
9. Transcription Factor ELK3 Promotes Stemness and Oxaliplatin Resistance of Glioma Cells by Regulating RNASEH2A.
Mei Y; Chen D; He S; Ye J; Luo M; Wu Q; Huang Y
Horm Metab Res; 2023 Feb; 55(2):149-155. PubMed ID: 36638810
[TBL] [Abstract][Full Text] [Related]
10. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with
Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D
Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329
[No Abstract] [Full Text] [Related]
11. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
12. Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells.
Chadchankar J; Korboukh V; Conway LC; Wobst HJ; Walker CA; Doig P; Jacobsen SJ; Brandon NJ; Moss SJ; Wang Q
PLoS One; 2019; 14(11):e0225145. PubMed ID: 31703099
[TBL] [Abstract][Full Text] [Related]
13. The CDK4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation.
Amari K; Sasagawa S; Imayoshi N; Toda Y; Hosogi S; Imamura T; Ashihara E
Biochem Biophys Res Commun; 2022 Jan; 588():147-153. PubMed ID: 34954522
[TBL] [Abstract][Full Text] [Related]
14. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
Ma F; Wang H; Liu K; Wang Z; Chen S
Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
[TBL] [Abstract][Full Text] [Related]
15. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5.
Zhang Z; Hu X; Kuang J; Liao J; Yuan Q
Cell Mol Biol Lett; 2020; 25():29. PubMed ID: 32351584
[TBL] [Abstract][Full Text] [Related]
17. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract][Full Text] [Related]
18. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.
Tian Z; D'Arcy P; Wang X; Ray A; Tai YT; Hu Y; Carrasco RD; Richardson P; Linder S; Chauhan D; Anderson KC
Blood; 2014 Jan; 123(5):706-16. PubMed ID: 24319254
[TBL] [Abstract][Full Text] [Related]
19.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]